Discussions highlight the potential of the formulation to control hormonal activity related to acne, with phrases like 'could be a game-changer' indicating optimism. The tone is generally informative, referencing the biochemical effects like reduced lipid production and androgen levels, which underscores their recognition of the research's significance and real-world implications.
AgreementModerate agreement
Most discussions acknowledge the potential benefits of the dermocosmetic formulation in modulating sebum production, indicating general support for the research findings.
InterestModerate interest
Participants show moderate curiosity, with some expressing interest in how the formulation could be a non-toxic alternative for acne management.
EngagementNeutral engagement
Engagement appears moderate, as some comments reference specific mechanisms or ask questions, but many others remain superficial.
ImpactModerate impact
The overall tone suggests that the publication could influence future acne treatments, though the discussions stop short of wide-scale endorsement or critical evaluation.
Abstract in brief
The study explores a cosmetic formulation called DTRW that may help prevent acne by targeting the overproduction of sebum, which is driven by excess androgens like testosterone and DHT in the skin.
When human sebocytes (skin oil-producing cells) are treated with DTRW, there is a significant reduction in lipid and fatty acid production, as well as decreases in key androgenic substances, suggesting it can modulate hormonal activity linked to acne.
The findings suggest that DTRW could be an effective, non-toxic option for managing acne by preventing sebaceous gland dysregulation and reducing excessive sebum production, which are primary factors in acne development.]
Steroid 5-alpha-reductase deficiency is a genetic disorder causing male pseudohermaphroditism, leading to ambiguous genitalia at birth. During puberty, virilization occurs but with low dihydrotestosterone levels…
The study explores a cosmetic formulation called DTRW that may help prevent acne by targeting sebum overproduction driven by excess androgens like testosterone and DHT in the skin. It shows significant reduction in…
Use of Rho Kinase Inhibitors in Ophthalmology: A Review of The ...
News
... 13503 in clinical trials, is a ROCK 2018. For the PubMed search, Medical ... 2016;94(1):e26-34. 10.3109/02713683.2013.874 444 pmid: 24502505 doi: 10.1111/aos.